Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Bisaga

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
The American Journal on Addictions|June 8, 2025
Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trialsMatisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
Advances in Medical Education and Practice|July 9, 2020
Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) CurriculumJeremy D Kidd, Jennifer L Smith, Mei-Chen Hu, et al.
Drug and Alcohol Dependence|February 8, 2022
Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trialsMatisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
Journal of the American Association of Nurse Practitioners|September 27, 2023
"Because of this rotation, this is what I want to do": Implementation and evaluation of a telehealth opioid use disorder clinical placement for nurse practitioner studentsRachel French, Erica Lyons, Allison Schachter, et al.
Drug and Alcohol Dependence|December 21, 2004
Utility of lead-in period in cocaine dependence pharmacotherapy trialsAdam Bisaga, Efrat Aharonovich, Fatima Garawi, et al.
Journal of Substance Abuse Treatment|June 19, 2007
Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependenceFrances R Levin, Adam Bisaga, Wilfrid Raby, et al.
Drug and Alcohol Dependence|October 7, 2014
Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?Meredith A Kelly, Martina Pavlicova, Andrew Glass, et al.
Journal of Substance Abuse Treatment|February 25, 2014
A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
The American Journal on Addictions|May 9, 2008
Dextromethorphan and quinidine combination for heroin detoxificationEvaristo Akerele, Adam Bisaga, Maria A Sullivan, et al.
The American Journal on Addictions|May 16, 2009
Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependenceWilfrid Noel Raby, Kenneth M Carpenter, Jami Rothenberg, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
The American Journal on Addictions|June 8, 2025
Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trialsMatisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
Advances in Medical Education and Practice|July 9, 2020
Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) CurriculumJeremy D Kidd, Jennifer L Smith, Mei-Chen Hu, et al.
Drug and Alcohol Dependence|February 8, 2022
Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trialsMatisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
Journal of the American Association of Nurse Practitioners|September 27, 2023
"Because of this rotation, this is what I want to do": Implementation and evaluation of a telehealth opioid use disorder clinical placement for nurse practitioner studentsRachel French, Erica Lyons, Allison Schachter, et al.
Drug and Alcohol Dependence|December 21, 2004
Utility of lead-in period in cocaine dependence pharmacotherapy trialsAdam Bisaga, Efrat Aharonovich, Fatima Garawi, et al.
Journal of Substance Abuse Treatment|June 19, 2007
Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependenceFrances R Levin, Adam Bisaga, Wilfrid Raby, et al.
Drug and Alcohol Dependence|October 7, 2014
Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?Meredith A Kelly, Martina Pavlicova, Andrew Glass, et al.
Journal of Substance Abuse Treatment|February 25, 2014
A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
The American Journal on Addictions|May 9, 2008
Dextromethorphan and quinidine combination for heroin detoxificationEvaristo Akerele, Adam Bisaga, Maria A Sullivan, et al.
The American Journal on Addictions|May 16, 2009
Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependenceWilfrid Noel Raby, Kenneth M Carpenter, Jami Rothenberg, et al.
Pageof 10